Patents Assigned to Breath Limited
-
Publication number: 20120148638Abstract: A dpi formulation comprises a solvate of beclomethasone with a non-cyclic, straight or branched C5-C7 hydrocarbon. The solvate particles are of size 0.5 to 10 microns and are obtained by crystallization of the steroid in the presence of ultrasound.Type: ApplicationFiled: August 16, 2010Publication date: June 14, 2012Applicant: BREATH LIMITEDInventors: Ian Cameron Gardner McAffer, Peter Ernest Tasko, Susheela Ginafrancesco, Graham John Swift
-
Publication number: 20120135055Abstract: A dpi formulation comprises a solvate of beclomethasone and is substantially free of excipient and free of carrier. The solvate particles are of size 0.5 to 10 microns and are obtained by crystallization of the steroid in the presence of ultrasound.Type: ApplicationFiled: August 16, 2010Publication date: May 31, 2012Applicant: BREATH LIMITEDInventors: Ian Cameron Gardner Mcaffer, Peter Ernest Tasko, Susheela Ginafrancesco, Graham John Swift
-
Patent number: 8084501Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.Type: GrantFiled: January 20, 2006Date of Patent: December 27, 2011Assignees: Breath Limited, Resolution Chemicals LimitedInventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen K. Jette, Gary C. Visor, Ian G. C. McAffer, Peter Tasko
-
Publication number: 20110131929Abstract: An ampoule contains a solution, e.g. an inhalation or injectable pharmaceutical, and an outer surface of the ampoule is coated with a metal or metal compound so as to reduce moisture egress from the ampoule and reduce contamination of ampoule contents from external sources. Labels are easily applied to the coating.Type: ApplicationFiled: December 6, 2010Publication date: June 9, 2011Applicant: BREATH LIMITEDInventors: Ian Gardner Cameron McAffer, Peter Ernest Tasko
-
Publication number: 20080257481Abstract: An ampoule contains a solution, e.g. an inhalation or injectable pharmaceutical, and an outer surface of the ampoule is coated with a metal or metal compound so as to reduce moisture egress from the ampoule and reduce contamination of ampoule contents from external sources. Labels are easily applied to the coating.Type: ApplicationFiled: May 9, 2008Publication date: October 23, 2008Applicant: Breath LimitedInventors: Ian Gardner Cameron McAffer, Peter Ernest Tasko
-
Publication number: 20060270735Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.Type: ApplicationFiled: January 20, 2006Publication date: November 30, 2006Applicant: BREATH LIMITEDInventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen Jette, Gary Visor, Ian McAffer, Peter Tasko
-
Patent number: 6863865Abstract: A method of sterilizing a pharmaceutical composition containing a suspension of a pharmaceutical comprises rapidly heating the pharmaceutical composition from ambient temperature to an elevated temperature, maintaining it at or above the elevated temperature for a period of time, and rapidly cooling the pharmaceutical composition to ambient temperature.Type: GrantFiled: September 30, 2002Date of Patent: March 8, 2005Assignee: Breath LimitedInventors: Ian G. C. McAffer, Kailash S. Purohit
-
Publication number: 20030103864Abstract: A method of sterilizing a pharmaceutical composition containing a suspension of a pharmaceutical comprises rapidly heating the pharmaceutical composition from ambient temperature to an elevated temperature, maintaining it at or above the elevated temperature for a period of time, and rapidly cooling the pharmaceutical composition to ambient temperature.Type: ApplicationFiled: September 30, 2002Publication date: June 5, 2003Applicant: Breath LimitedInventors: Ian G.C. McAffer, Kailash S. Purohit